ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,956Medicare Part D Prescriptions Filled, Including Refills

Rank: 76 out of 2094

$1.11M Total Retail Price of All Prescriptions

Rank: 68 out of 2094

779 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 779 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

3% of this provider’s 779 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 12,685 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$79 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
SIMVASTATIN 743 704 1 1
LEVOTHYROXINE SODIUM 694 645 2 3
AMLODIPINE BESYLATE 454 441 3 2
LISINOPRIL 385 360 4 7
METFORMIN HCL 348 317 5 8
FUROSEMIDE 283 269 6 6
OMEPRAZOLE 261 239 7 4
ZOLPIDEM TARTRATE 253 226 8 14
METOPROLOL TARTRATE 249 230 9 10
PRAVASTATIN SODIUM 211 184 10 18
DONEPEZIL HCL 193 187 11 20
WARFARIN SODIUM 184 182 12 11
ATORVASTATIN CALCIUM 183 149 13 5
ATENOLOL 173 173 14 21
NEXIUM 171 141 15 16
FLUTICASONE PROPIONATE 154 133 16 41
CRESTOR 147 133 17 15
RAMIPRIL 142 124 18 48
GLIMEPIRIDE 141 137 19 31
METOPROLOL SUCCINATE 139 118 20 9
CLOPIDOGREL 138 135 21 22
AMLODIPINE BESYLATE-BENAZEPRIL 132 127 22 58
CITALOPRAM HBR 127 106 23 47
MELOXICAM 127 120 23 49
NAMENDA 123 123 25 32
ISOSORBIDE MONONITRATE ER 121 95 26 57
CARVEDILOL 118 116 27 19
HYDROCHLOROTHIAZIDE 117 110 28 12
PLAVIX 115 109 29 38
BISOPROLOL-HYDROCHLOROTHIAZIDE 114 102 30 148
TAMSULOSIN HCL 109 96 31 29
DIOVAN 104 99 32 13
KLOR-CON M20 104 96 32 106
SERTRALINE HCL 100 90 34 26
PANTOPRAZOLE SODIUM 100 99 34 37
PAROXETINE HCL 97 97 36 77
QUINAPRIL HCL 94 89 37 123
AZITHROMYCIN 92 85 38 27
LOVAZA 91 66 39 53
METHYLPREDNISOLONE 89 79 40 127
POTASSIUM CHLORIDE 86 79 41 24
ALENDRONATE SODIUM 82 72 42 30
GABAPENTIN 80 79 43 23
HALOBETASOL PROPIONATE 77 68 44 368
CIPROFLOXACIN HCL 75 65 45 81
FAMOTIDINE 75 71 45 34
TRAMADOL HCL 75 66 45 33
SYNTHROID 74 61 48 44
TRICOR 73 64 49 99
LOSARTAN POTASSIUM 73 66 49 17
POLYETHYLENE GLYCOL 3350 70 51 51 75
LANTUS 69 57 52 66
PRANDIN 69 52 52 125
SINGULAIR 67 51 54 64
RANITIDINE HCL 67 62 54 80
GLIPIZIDE 65 60 56 82
FINASTERIDE 64 64 57 97
JANUVIA 64 60 57 35
OXYBUTYNIN CHLORIDE 63 63 59 224
SPIRIVA 63 60 59 60
MUPIROCIN 60 57 61 117
INDOMETHACIN 60 51 R 61 482
LIPITOR 58 57 63 39
LISINOPRIL-HYDROCHLOROTHIAZIDE 57 55 64 55
MIRTAZAPINE 57 53 64 43
CILOSTAZOL 56 56 66 204
ESCITALOPRAM OXALATE 55 49 67 46
CLOTRIMAZOLE-BETAMETHASONE 54 35 68 91
AMOXICILLIN 54 49 68 147
CELEBREX 53 49 70 74
TRIAMTERENE-HCTZ 53 39 70 87
VESICARE 53 47 70 152
NAPROXEN 52 46 73 84
INSULIN SYRINGE 51 47 74 143
TERAZOSIN HCL 50 50 75 240
ALLOPURINOL 50 49 75 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 6, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.